Target intelligence / Profile preview

Fast skeletal troponin C (sTnC)

Target
sTnC
Molecular classification
Calcium-binding protein, Regulatory protein, EF-hand protein, Other
01

Overview

Fast skeletal troponin C is a calcium-binding regulatory protein found exclusively in fast-twitch (type II) skeletal muscle fibers, encoded by the TNNC2 gene[1][2][3][4][5][6]. It is one of three subunits of the troponin complex (along with troponin I and troponin T) that regulates striated muscle contraction in response to changes in intracellular calcium concentration. Upon Ca^2+^ binding, fast skeletal troponin C (sTnC) undergoes a conformational change that interacts with the troponin I subunit, leading to tropomyosin movement on actin filaments and ultimately permitting actin-myosin cross-bridge cycling and muscle contraction[1][2][5]. Fast skeletal troponin C is homologous but distinct from cardiac and slow skeletal muscle isoforms, with unique structural characteristics and tissue-restricted expression. Mutations in the TNNC2 gene have been implicated in certain congenital myopathies, though sTnC itself is not a common therapeutic target. Some investigational or off-label calcium sensitizers interact with the broader troponin complex but do not selectively target the skeletal isoform[1][3][6].

Other names
Skeletal muscle troponin CTroponin C, fast skeletal muscleTNNC2 (gene symbol)Troponin C type 2
02

Mechanism of action

Calcium sensitization by stabilizing Ca^2+^-bound conformation (for calcium sensitizers targeting troponin complex); Modulation of actin-myosin interaction through troponin complex

03

Biological functions

Calcium sensingRegulation of skeletal muscle contractionMediator of thin filament activation
04

Disease associations

Other (mutations implicated in congenital muscle disorders, certain myopathies)
05

Safety considerations

Modulation of troponin C function can potentially impair or overstimulate skeletal muscle contraction, risking muscle weakness or hypercontractility
06

Interacting drugs

Levosimendan (off-target/indirect activity)

2 more in the full profile.

07

Biomarkers

None established for clinical use specific to fast skeletal troponin C

Beyond the preview

Go deeper on Fast skeletal troponin C (sTnC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fast skeletal troponin C (sTnC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call